Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

about

Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis ‐ Data Registry

P921

Q63534862-8160A09D-9B25-4EA8-96FD-774E602DC42D Q64221668-4C3CD704-C8B9-4161-A829-588A001173E6

P921

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

Item

http://www.wikidata.org/entity/Q58773636

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

@en

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

@nl

type

Item

label

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

@en

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

@nl

prefLabel

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

@en

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

@nl

P1476

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

@en

P2093

Andrea Jewell

http://www.w3.org/2001/XMLSchema#string

Dineo Khabele

http://www.w3.org/2001/XMLSchema#string

Megan McMahon

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study.

Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study

Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry

Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis.

Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis.

A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies.

Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality.

P304

296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS10090296

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30200420

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

cancer research

chemotherapy

P932

6162496

http://www.w3.org/2001/XMLSchema#string

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

about

P921

P921

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932